Thoma Bravo Will Pay $20.25 a Share for Accelerant — 75 Cents Less Than Its IPO Price 13 Months Ago

by Maya Okafor · August 13, 2026

Deals & Listings Reporter, The SmallCap Signal

Accelerant Holdings agreed Thursday to be acquired by Thoma Bravo for $20.25 a share in cash, in a transaction the private equity firm's announcement valued at more than $4 billion on an enterprise basis. The price represents a 49% premium to Accelerant's closing share price on August 12, 2026, and it sent the stock up 43.35% to a close of $19.51, according to Stock Analysis price data. Investrade's mid-morning market look described the deal in the same terms, noting the all-cash structure and the $4 billion-plus headline figure.

The premium is real and the exit price is not. Accelerant priced its initial public offering at $21 a share in late July 2025, above a marketed range of $18 to $20, according to Renaissance Capital. The upsized deal sold 34.5 million shares — 59% newly issued by the company and 41% from selling shareholders — raising $724 million and giving the specialty-insurance platform a fully diluted market capitalization of about $4.7 billion at the time. The underwriting syndicate ran to nine banks led by Morgan Stanley, Goldman Sachs, BMO Capital Markets, RBC Capital Markets and Wells Fargo Securities. Thirteen months later, the negotiated take-private price sits 75 cents, or roughly 3.6%, below where public investors first bought in.

That gap is a function of what happened in between. A Yahoo Finance report in February noted the stock was changing hands at $10.95, down about 48% from its IPO price. It had recovered some ground since: Accelerant closed at $13.61 on August 12, according to Stock Analysis data, which still left the shares roughly 35% below their listing price before Thoma Bravo showed up. GuruFocus, in its summary of the transaction, put Accelerant's market capitalization at $2.97 billion and flagged trailing twelve-month losses, describing conventional earnings-based valuation as not meaningful given the company's negative margins, while noting three-year revenue growth of 53.1%.

Accelerant operates what it calls a risk exchange: a data-driven marketplace that connects specialty insurance underwriters with the capital partners willing to back their risk, layering on analytics, distribution management and underwriting capacity. Renaissance Capital's IPO note counted 232 members and 96 risk capital partners on the platform as of March 31, 2025. The company is a Cayman Islands entity listed on the New York Stock Exchange under the ticker ARX. Chief Executive Jeff Radke said in the announcement that returning to private ownership alongside Thoma Bravo's technology and software expertise would let the company make investments to further position its data-fueled platform.

The mechanics of the deal are unusually settled for an announcement day, which is part of why the stock still stopped some 74 cents short of the offer. Entities affiliated with Altamont Capital Partners, which hold approximately 82% of Accelerant's voting rights, have committed to vote in favor, and both Altamont and the company's founders will retain equity in the private entity after closing. Shareholder approval remains a formal closing condition. Accelerant's board formed a special committee that retained Houlihan Lokey as financial adviser and Conyers Dill & Pearman as counsel; Morgan Stanley advised the company, with Paul Hastings, Sidley Austin and Maples Group on legal. Thoma Bravo worked with BMO Capital Markets and Wells Fargo on the financial side and Goodwin Procter, Skadden Arps and Walkers on legal, with Ropes & Gray advising Altamont. No go-shop provision was described in the release.

The timeline is the striking part. The parties expect the transaction to close in the first half of 2027 — as much as ten months away — with the delay driven by insurance regulatory approvals across the multiple jurisdictions in which Accelerant's underwriting members operate. To compensate holders for that wait, the agreement carries a ticking fee accruing at 6% per annum if closing is pushed out by certain of those insurance regulatory approvals, according to filing summaries published by StockTitan. Accelerant issued its second-quarter results on Thursday as scheduled but cancelled the accompanying earnings call because of the announcement.

Accelerant was not the only mid-cap listing to draw a sale process Thursday. The Irish Times reported that the board of Ardagh Holdings has instructed advisers to prepare for a potential sale of its stake in Ardagh Metal Packaging (NYSE: AMBP), the beverage-can maker it spun out through a SPAC merger in August 2021. The holding company said it may sell some or all of its equity interests and could also buy in the remaining shares to facilitate a sale of the whole business to a third party. Ardagh Holdings owns 76% of the metal packaging business, which the paper valued at a $3.14 billion market capitalization on Thursday and which generated $5.5 billion of sales in 2025 across 23 plants in nine countries. Evercore International Partners is financial adviser and Kirkland & Ellis International is legal counsel. Ardagh said it has not set a deadline for the process. Shares of AMBP jumped 11.24% in Thursday's pre-market on the news, according to TheStreet's live market blog, but gave most of that back during the session: StockInvest.us data put the close at $5.28, a gain of 4.35% on the day.

The Ardagh situation carries a debt history that shapes the sale logic. The Irish Times noted that bondholders owed $4.2 billion took control of the group late last year after its borrowings became unsustainable following pandemic disruption and the subsequent rise in interest rates — the same 2021-vintage capital structure that the original SPAC transaction helped fund, generating $3.3 billion of cash for the parent at the time. The operating business itself has been improving: second-quarter sales rose 18% to $1.7 billion and adjusted EBITDA rose 14% to $240 million, with full-year adjusted EBITDA guidance raised to $775 million to $790 million from a prior $750 million to $775 million.

Two deals do not make a trend, but they rhyme in a way that matters for anyone holding recently listed small- and mid-cap paper. Both companies came to the public market through a hot window — one via SPAC in 2021, one via a traditional IPO in 2025 — both traded well below their debut valuations, and both are now the subject of processes controlled by concentrated holders rather than by the public float. In Accelerant's case, an 82% voting bloc has already committed its votes; in Ardagh's, a 76% owner is running the sale. Minority public shareholders in both situations are price-takers.

What to watch from here is the spread and the calendar. Accelerant closed Thursday at $19.51 against a $20.25 offer, a gap of about 3.7% for a deal not expected to close until the first half of 2027 — a discount that reflects both the time value and the insurance regulatory approvals that triggered the 6% ticking fee provision in the first place. For Ardagh Metal Packaging, no deadline has been set and no buyer identified, which means Thursday's move — an 11% pre-market pop that settled into a gain of roughly 4% — priced a process, not a transaction. Neither company has an obligation to update the market before its next scheduled disclosure.